A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis

Clinical trial NCT06738719 · COMPLETED

Trial details

NCT number: NCT06738719
Sponsor: Celltrion
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderately to Severely Active Rheumatoid Arthritis

Start date: 2025-01-03
Primary completion: 2025-06-25
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.